Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Li Qiang Investigates Biopharmaceutical Industry Development, Stresses to Increase Policy Support to Promote Industry Quality Upgrade
Recommend 35 Positive 68 Negative 13 |
||||
|
||||
|
Chinese Premier Li Qiang accentuated during his investigation of the biopharmaceutical industry development in Beijing yesterday (20th) that there should be an increase in high-quality technological supply and policy support, focusing on promoting the quality upgrade of the biopharmaceutical industry. The aim is to research and produce more high-quality and efficient new drugs, continuously enhancing the health and well-being of the people. During the investigation, Li chaired a symposium. After listening to speeches from relevant enterprises and leaders in investment, R&D, and medical institutions, he highlighted the importance of comprehensively empowering industry development with AI, enhancing the intelligence level of drug R&D, clinical trials, diagnosis and treatment, and production and distribution. He stressed the need to reinforce policy coordination and collaboration in product development, review and approval, and management usage, optimizing the drug procurement and negotiation pricing mechanism, and increasing guidance on the application of high-level innovative drugs. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
